Irene Jobson
Overview
Explore the profile of Irene Jobson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
84
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bancroft E, Page E, Brook M, Pope J, Thomas S, Myhill K, et al.
BJU Int
. 2024 Jun;
134(3):484-500.
PMID: 38839570
Objectives: To report the long-term outcomes from a longitudinal psychosocial study that forms part of the 'Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in men...
2.
Page E, Bancroft E, Brook M, Assel M, Hassan Al Battat M, Thomas S, et al.
Eur Urol
. 2019 Sep;
76(6):831-842.
PMID: 31537406
Background: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2...
3.
Mikropoulos C, Hutten Selkirk C, Saya S, Bancroft E, Vertosick E, Dadaev T, et al.
Br J Cancer
. 2018 Mar;
118(6):e17.
PMID: 29509747
This corrects the article DOI: 10.1038/bjc.2017.429.
4.
Mikropoulos C, Hutten Selkirk C, Saya S, Bancroft E, Vertosick E, Dadaev T, et al.
Br J Cancer
. 2018 Jan;
118(2):266-276.
PMID: 29301143
Background: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a...